ArticleJournal of biomedical science2022

Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma.

You-Liang Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.